As of 2024-12-12, the Fair Value of Seres Therapeutics Inc (MCRB) is -0.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.90 USD, the upside of Seres Therapeutics Inc is -182.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -70.30 | -89.10 | -65.60 | -250.20 | -113.72 | -117.78 |
| YoY growth | 28.92% | -26.74% | 26.37% | -281.40% | 54.55% | -39.66% |
| Market Cap (mil) | 153.67 |
| P/E | |
| Forward P/E |
| EPS | -0.15 |
| Avg earnings growth rate | -39.66% |
| TTM earnings | -25.48 |